Found 1410 matching trials
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
PHASE1Background:
X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
PHASE2This trial is designed to expand the currently available data on the safety...
Location
ECOGENE-21 Clinical Trial Center / Centre de santé et de services sociaux de Chicoutimi
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
PHASE1RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
MultiPoint Pacing IDE Study
PHASE3This IDE study is a prospective, randomized, double-blind, multi-center cli...
Location
Heart Center Research, LLC.
Characteristics of Lyme Arthritis
N/ALyme disease is due to Borrelia burgdorferi sensu lato and is transmitted b...
Location
Laboratoire de Bacteriologie - Ptm
Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations
PHASE1The purpose of this clinical trial is to examine the safety of gene therapy...
Location
Hadassah Medical Organization
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine
PHASE1In December 2019, viral pneumonia caused by a novel beta-coronavirus (Covid...
Location
Shenzhen Geno-immune Medical Institute
A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema
PHASE1This is a Phase 1/2, single-arm, open-label, dose-escalation and dose-expan...
Status
Active Not Recruiting
Location
AllerVie Clinical Research
Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD)
PHASE1Chronic Granulomatous Disease (CGD) is a rare inherited disorder in which p...
Location
Great Ormond Street Hospital for Children NHS Trust
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
PHASE1The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS